viral vectors

Contract development and manufacturing organization Minaris has created a dedicated viral vectors business unit as part of a reorganization into three specialized divisions. The move signals a sharpened focus on distinct service areas, with viral vectors an increasingly important capability for cell and gene therapy production. Industry observers see it as part of broader consolidation and specialization trends across the CDMO sector.